Literature DB >> 25755728

Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis.

Mona Diab-Assaf1, Raefa Abou-Khouzam1, Nina Saadallah-Zeidan1, Khaled Habib2, Nizar Bitar3, Walid Karam1, Bertrand Liagre4, Steve Harakeh5, Rania Azar1.   

Abstract

Cap dependent translation is mainly regulated at the level of the eukaryotic initiation factor 4E (eIF4E), the activity of which is controlled by phosphorylation and sequestration by its well established regulator, 4E binding protein 1 (4E-BP1). Both eIF4E and 4E-BP1 have been shown to be involved in the malignant progression of multiple human cancers, including colorectal cancer. However, the data on determining the expression of eIF4E, 4E-BP1 and their phosphorylated forms simultaneously in a single patient with colorectal cancer is lacking. Therefore the aim of our study was to explore the roles of these factors in colorectal carcinogenesis by immunohistostaining colorectal tissues (normal, low grade adenoma, high grade adenoma, and adenocarcinoma). Our results showed that the expression levels of eIF4E increased steadily as the cancer progressed from the case of benign dysplasia to an adenocarcinoma; all the while maintaining an unphosphorylated form. On the other hand, total expression levels of 4E-BP1 increased only in the premalignant state of the disease and decreased (but highly phosphorylated or inactivated) or abolished upon malignancy. Taken together, our findings suggest that strong correlations exist between the expression of eIF4E (not p-eIF4E) and tumor grade providing evidence that eIF4E expression plays a pivotal role in the malignant progression of colorectal cancer. Moreover, 4E-BP1 showed a bi-phasic level of expression during carcinogenesis, which is expressed only in hyperplasic or dysplastic tissues as an endogenous tumor suppressor molecule.

Entities:  

Keywords:  4E-BP1; Colorectal cancer; eIF4E; immunuhistochemistry; translational control

Mesh:

Substances:

Year:  2015        PMID: 25755728      PMCID: PMC4348849     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  43 in total

1.  Elevated expression of eIF4E in confined early breast cancer lesions: possible role of hypoxia.

Authors:  R J DeFatta; E A Turbat-Herrera; B D Li; W Anderson; A De Benedetti
Journal:  Int J Cancer       Date:  1999-02-09       Impact factor: 7.396

2.  Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon.

Authors:  H J Berkel; E A Turbat-Herrera; R Shi; A de Benedetti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-06       Impact factor: 4.254

3.  Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor.

Authors:  D L Sorrells; C Meschonat; D Black; B D Li
Journal:  J Surg Res       Date:  1999-07       Impact factor: 2.192

4.  Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.

Authors:  Nobuhiko Seki; Tasaburo Takasu; Koichi Mandai; Masao Nakata; Hideyuki Saeki; Yuji Heike; Ichiro Takata; Yoshihiko Segawa; Toshiaki Hanafusa; Kenji Eguchi
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

5.  Role of the RNA-binding protein HuR in colon carcinogenesis.

Authors:  Isabel López de Silanes; Jinshui Fan; Xiaoling Yang; Alan B Zonderman; Olga Potapova; Ellen S Pizer; Myriam Gorospe
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

6.  eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.

Authors:  Jeremy R Graff; Bruce W Konicek; Rebecca L Lynch; Chad A Dumstorf; Michele S Dowless; Ann M McNulty; Stephen H Parsons; Leslie H Brail; Bruce M Colligan; Jonathan W Koop; Bernadette M Hurst; James A Deddens; Blake L Neubauer; Louis F Stancato; Harry W Carter; Larry E Douglass; Julia H Carter
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

7.  Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.

Authors:  Josep Castellvi; Angel Garcia; Carmen Ruiz-Marcellan; Javier Hernández-Losa; Vicente Peg; Mayte Salcedo; Antonio Gil-Moreno; Santiago Ramon y Cajal
Journal:  Hum Pathol       Date:  2009-05-09       Impact factor: 3.466

8.  Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues.

Authors:  Songqing Fan; Suresh S Ramalingam; John Kauh; Zhiheng Xu; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Biol Ther       Date:  2009-08-08       Impact factor: 4.742

9.  Pancreatic tumours escape from translational control through 4E-BP1 loss.

Authors:  Y Martineau; R Azar; D Müller; C Lasfargues; S El Khawand; R Anesia; J Pelletier; C Bousquet; S Pyronnet
Journal:  Oncogene       Date:  2013-04-08       Impact factor: 9.867

10.  Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer.

Authors:  Ivan Topisirovic; Nadeem Siddiqui; Slobodanka Orolicki; Lucy A Skrabanek; Mathieu Tremblay; Trang Hoang; Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

View more
  6 in total

1.  Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma.

Authors:  Xue-Mei Jiang; Xiang-Nan Yu; Ren-Zheng Huang; Hai-Rong Zhu; Xiao-Peng Chen; Ju Xiong; Zheng-Yi Chen; Xiao-Xi Huang; Xi-Zhong Shen; Ji-Min Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-06       Impact factor: 4.553

2.  Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasis.

Authors:  Tao Xu; Yuanyuan Zong; Lipan Peng; Shuai Kong; Mingliang Zhou; Jianqiang Zou; Jinglei Liu; Ruizheng Miao; Xichao Sun; Leping Li
Journal:  Onco Targets Ther       Date:  2016-02-19       Impact factor: 4.147

3.  Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.

Authors:  Nicole Golob-Schwarzl; Caroline Schweiger; Carina Koller; Stefanie Krassnig; Margit Gogg-Kamerer; Nadine Gantenbein; Anna M Toeglhofer; Christina Wodlej; Helmut Bergler; Brigitte Pertschy; Stefan Uranitsch; Magdalena Holter; Amin El-Heliebi; Julia Fuchs; Andreas Punschart; Philipp Stiegler; Marlen Keil; Jens Hoffmann; David Henderson; Hans Lehrach; Christoph Reinhard; Christian Regenbrecht; Rudolf Schicho; Peter Fickert; Sigurd Lax; Johannes Haybaeck
Journal:  Oncotarget       Date:  2017-09-05

Review 4.  Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development.

Authors:  Christos Vaklavas; Scott W Blume; William E Grizzle
Journal:  Front Oncol       Date:  2017-07-26       Impact factor: 6.244

5.  Clinical Significance of Eukaryotic Initiation Factor 4E (eIF4E) Level among Cases Suffering Basal Cell Carcinoma of Skin.

Authors:  Baiyu Han; Qinying Zhang; GaiLan Li; Rui Zhang; Hengjin Li
Journal:  Med Sci Monit       Date:  2019-10-23

Review 6.  Cell Fate Control by Translation: mRNA Translation Initiation as a Therapeutic Target for Cancer Development and Stem Cell Fate Control.

Authors:  Hyun-Jung Kim
Journal:  Biomolecules       Date:  2019-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.